Aarhus N

• A Phase II, Open-label, Multicenter Study Testing Teclistamab in Combination with Pomalidomide Administered in Alternative Fashion in Partic … Pending
  2025-522114-23-00 4 Multiple myeloma (RRMM)
• Nordic PREdnisolon for VEstibular NeuriTis Study – an investigator-driven, triple blind, placebo controlled randomized trial Pending
  2025-522399-10-00 5 Vestibular neuritis
• Molecularly Tailored Therapy versus Standard Care in Advanced Pancreatic Cancer Pending
  2025-522431-34-00 4 Advanced pancreatic cancer
• A research study to see how NNC0487-0111 affects the body’s energy use after a weight loss in adults living with obesity, compared to a low- … Pending
  2025-522744-40-00 3 Obesity
• Osteogenesis Imperfecta Trial of AGA2115 for ADUlts with COL1A1 and/or COL1A2 GeNetic Variations (IDUN) Pending
  2025-522951-24-00 4 Osteogenesis Imperfecta
• An extension study to investigate the long-term safety and tolerability of itepekimab in adult participants with inadequately controlled chr … Pending
  2025-522983-33-00 5 Chronic rhinosinusitis with nasal polyps
• A Phase 1, Open-Label, Multicenter Study of INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies Pending
  2025-523130-11-00 1 Hematological malignancies
• A study to find out how nerandomilast is tolerated, handled by the body, and if it helps children and adolescents with interstitial lung dis … Pending
  2025-523369-32-00 5 Fibrosing interstitial lung disease
• A study in people with advanced extrapulmonary neuroendocrine cancer to compare obrixtamig plus carboplatin and etoposide treatment with sta … Pending
  2025-523869-22-00 5 advanced or metastatic extrapulmonary neuroendocrine carcinoma
• Impact of treatment with TransCon PTH on Quality of Life, cognitive function, brain structure, and cerebral capillary bloodflow in patients … Pending
  2025-523930-14-00 6 Hypoparathyroidism
• Cevostamab in Combination with Pomalidomide and Dexamethasone Versus Standard of Care in Patients with Previously Treated Multiple Myeloma Pending
  2025-524028-23-00 5 Multiple Myeloma
• Self-Assessment Method for Statin side-effects Or Nocebo 2 Pending
  2025-524955-30-01 11 Cardiovascular diseases
• A Randomized, Double-Blind, Phase 3 Study of Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D–Mutated Metastatic P … Pending
  2025-525009-18-00 5 Pancreatic Ductal Adenocarcinoma
• RESET C2 Pending
  2026-525214-62-00 4 Localised dMMR Colon Cancer
• A randomized, double blind, placebo-controlled, phase II, multicentre trial to explore the efficacy and safety of oral AP1189 tablets admini … Pending
  2026-525343-33-00 4 Polymyalgia rheumatica
• A multicentre, adaptive, randomised, multidomain, platform trial for dose optimization in the treatment of adult patients with haematologica … Pending
  2026-525658-13-00 6 Haematological diseases; any disorder that primarily affects the blood
• Obesity and Semaglutide in Type 1 Diabetes Therapy (OBES1TY): A Multicentre, Randomised, Double-Blinded, Placebo-Controlled, Investigator-In … Recruiting
  2025-522326-13-00 5 2026-06-29 Obesity defined by BMI equal to or higher than 30
• A clinical trial of MK-1045 in people with B-cell acute lymphoblastic leukemia Recruiting
  2025-522267-15-00 10 2026-06-24 ​Relapsed/refractory B-cell Acute Lymphoblastic Leukemia​
• A study to measure mirikizumab levels in breast milk of lactating participants receiving mirikizumab therapeutically for an approved indicat … Recruiting
  2025-522362-78-00 6 2026-06-08 severely active ulcerative colitis (US) and CD (Crohn’s disease)
• Crohn’s Head-to-Head Assessing Risankizumab Versus Guselkumab for One Year Recruiting
  2025-521590-13-00 5 2026-05-28 Moderately to Severely Active Crohn’s Disease
• An open-label extension (OLE) trial to evaluate long-term safety and tolerability of pelacarsen (TQJ230) Recruiting
  2024-519870-38-00 5 2026-05-11 Atherosclerotic cardiovascular disease (ASCVD)
• A clinical study of sacituzumab tirumotecan in people with ovarian cancer (MK-2870-021) Recruiting
  2023-508047-40-00 5 2026-04-30 Ovarian cancer
• A study to determine the safety and effect of antibodies against hepatitis D (the SAMBA-D study) Recruiting
  2025-522125-36-00 3 2026-04-22 Chronic hepatitis D infection
• Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants with Chronic Spontaneous Urticaria Recruiting
  2025-522878-36-00 5 2026-04-20 Chronic Spontaneous Urticaria

Showing 25–48 of 590 trials